139 related articles for article (PubMed ID: 15934276)
1. A better Code of Conduct.
Williams R
Can Fam Physician; 2005 May; 51():708-9. PubMed ID: 15934276
[No Abstract] [Full Text] [Related]
2. [A sunshine story].
Haug C
Tidsskr Nor Laegeforen; 2010 May; 130(9):919. PubMed ID: 20453939
[No Abstract] [Full Text] [Related]
3. Biased articles.
Friedman JH
Med Health R I; 2009 Mar; 92(3):70. PubMed ID: 19385378
[No Abstract] [Full Text] [Related]
4. Gifts to physicians from the pharmaceutical industry: an ethical analysis.
Marco CA; Moskop JC; Solomon RC; Geiderman JM; Larkin GL
Ann Emerg Med; 2006 Nov; 48(5):513-21. PubMed ID: 17052550
[TBL] [Abstract][Full Text] [Related]
5. What? Influenced by industry? Not me!
Mahowald MW; Cramer Bornemann MA
Sleep Med; 2005 Sep; 6(5):389-90. PubMed ID: 16099216
[No Abstract] [Full Text] [Related]
6. Taking issue with "Let's do lunch".
Gheseger J
Can Nurse; 2008 Jun; 104(6):5. PubMed ID: 18646296
[No Abstract] [Full Text] [Related]
7. Taking issue with "Let's do lunch".
Kohr R
Can Nurse; 2008 Jun; 104(6):5-6. PubMed ID: 18646299
[No Abstract] [Full Text] [Related]
8. Large or small, a gift is a gift is a gift.
Paris JJ
Am J Bioeth; 2003; 3(3):W30. PubMed ID: 14594482
[No Abstract] [Full Text] [Related]
9. Giving and receiving of gifts between pharmaceutical and medical specialists in Australia.
Wilson A
Intern Med J; 2006 Dec; 36(12):795-6; author reply 796-7. PubMed ID: 17096745
[No Abstract] [Full Text] [Related]
10. Guidelines for relationships between industry and the American College of Obstetricians and Gynecologists and its fellows. ACOG Committee Opinion No. 45.
American College of Obstetricians and Gynecologists [ACOG]. Committee on Ethics
ACOG Comm Opin; 1985 Oct; No. 45():1 p. PubMed ID: 11660326
[No Abstract] [Full Text] [Related]
11. Receiving gifts: a conflict of interest discussion.
Schwartz B
J Can Dent Assoc; 2005 Sep; 71(8):561-2. PubMed ID: 16202193
[No Abstract] [Full Text] [Related]
12. Conflicts of interest between physicians and the pharmaceutical industry and special interest groups.
Schetky DH
Child Adolesc Psychiatr Clin N Am; 2008 Jan; 17(1):113-25, ix-x. PubMed ID: 18036482
[TBL] [Abstract][Full Text] [Related]
13. Big pharma.
Campo D
Del Med J; 2007 Jun; 79(6):243-5. PubMed ID: 17621870
[No Abstract] [Full Text] [Related]
14. Thanks, but no thanks.
Bell H
Minn Med; 2008 Apr; 91(4):26-30. PubMed ID: 18549004
[No Abstract] [Full Text] [Related]
15. Medical students protest perks from drug companies.
Opar A
Nat Med; 2006 Oct; 12(10):1104. PubMed ID: 17024192
[No Abstract] [Full Text] [Related]
16. CMA guidelines concerning relationship of MDs and drug industry to be revised, board told.
Sullivan P
CMAJ; 1993 Jan; 148(2):273-5. PubMed ID: 11652162
[No Abstract] [Full Text] [Related]
17. The CMA's MD-drug industry guidelines offer advice, nothing more.
Woollard R
CMAJ; 1991 Dec; 145(11):1498-9. PubMed ID: 11649304
[No Abstract] [Full Text] [Related]
18. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
Brand R
State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
[No Abstract] [Full Text] [Related]
19. General Council to consider amendments to CMA policy on MDs' relationships with drug industry.
Williams JR
CMAJ; 1993 Aug; 149(3):335-7. PubMed ID: 11659649
[No Abstract] [Full Text] [Related]
20. On the need for probity when physicians interact with industry.
Scott IA
Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
